Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Electronic Medical Records Speed Genetic Research

By LabMedica International staff writers
Posted on 10 May 2011
A new study revealed that mining data from electronic medical records (EMRs) is a faster way to get insights into disease processes.

Recruiting thousands of patients to collect health data for genetic clues to disease is expensive and time consuming. More...
However, process of collecting data for genetic studies could be faster and cheaper by instead mining patient data that already exists in electronic medical records, according to new research.

In the study, researchers were able to cull patient information in EMRs from routine physicians' visits at five US sites that all used different brands of medical record software. The information allowed researchers to identify accurately patients with five kinds of diseases or health disorders--type 2 diabetes, dementia, peripheral arterial disease, cataracts, and cardiac conduction.

"The hard part of doing genetic studies has been identifying enough people to get meaningful results," said lead investigator Abel Kho, MD, an assistant professor of medicine at Northwestern University Feinberg School of Medicine (Chicago, IL, USA) and a physician at Northwestern Memorial Hospital. "Now we've shown you can do it using data that's already been collected in electronic medical records and can rapidly generate large groups of patients."

The study's findings were published April 20, 2011, in the journal Science Translational Medicine. To identify the diseases, Dr. Kho and colleagues searched the records using a series of criteria such as medications, diagnoses, and laboratory tests. They then tested their results against the gold standard-- review by physicians. The physicians validated the results, according to Dr. Kho. The electronic health records allowed researchers to identify patients' diseases with 73% to 98% accuracy.

The researchers also were able to reproduce previous genetic findings from prospective studies using the EMRs. The five institutions that participated in the study collected genetic samples for research. Patients agreed to the use of their records for studies.

Sequencing individuals' genomes is becoming faster and less expensive. It soon may be possible to include patients' genomes in their medical records, Dr. Kho noted. This would create a plentiful resource for genetic research. "With permission from patients, you could search electronic health records at not just five sites but 25 or 100 different sites and identify 10,000 or 100,000 patients with diabetes, for example," Dr. Kho said.

The larger the group of patients for genetic studies, the better the ability to detect rarer affects of the genes and the more detailed genetic sequences that cause a person to develop a disease. The study also revealed across-the-board weaknesses in institutions' electronic medical records. The institutions didn't do a good job of capturing race and ethnicity, smoking status, and family history, all which are important areas of study, Dr. Kho reported. "It shows we need to focus our efforts to use electronic medical records more meaningfully," he added.

The institutions participating in the study are part of a consortium called the Electronic Medical Records and Genomics Network (eMERGE). The research was supported by the US National Human Genome Research Institute with additional funding from the US National Institute of General Medical Sciences, both based in Bethesda, MD, USA.

Related Links:

Northwestern University Feinberg School of Medicine



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.